President Trump's Tylenol-Autism Claim Contradicts Scientific Consensus
President Trump controversially linked prenatal Tylenol use to autism, a claim largely rejected by global health authorities due to insufficient evidence, despite acetaminophen's approved safety.
PBS NewsHourDoctor challenges Trump administration's claims about acetaminophen and autism
Daily SignalEXCLUSIVE: HHS Official Responds to Women Popping Tylenol to Spite Trump
Daily SignalA Call for Common Sense in Health Care
Washington ExaminerFlorida surgeon general defends Trump’s Tylenol warning
Overview
President Trump announced a controversial link between Tylenol use during pregnancy and autism, a claim that lacks support from global health authorities.
Global health authorities and current research largely reject a conclusive link between prenatal acetaminophen use and autism due to insufficient scientific evidence.
Some research indicates prenatal acetaminophen use, especially late in pregnancy, may increase risks of ADHD, ASD, or other neurodevelopmental disorders in children.
Acetaminophen remains the only pain reliever approved and widely considered safe for use during pregnancy, offering a crucial option for managing discomfort.
Untreated fever and pain during pregnancy pose significant risks, including birth defects, preterm birth, low birth weight, and miscarriage, highlighting treatment necessity.
Analysis
Center-leaning sources frame this story by presenting Dr. Marty Makary as a credible, contrarian voice revealing a "bombshell" link between Tylenol and autism. They use laudatory language to establish his authority and emphasize a Harvard review to support his claims, creating a narrative of urgent public disclosure without including broader scientific consensus or alternative expert perspectives.